{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:08:57Z","timestamp":1771013337784,"version":"3.50.1"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.fct.2020.111805","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T07:56:46Z","timestamp":1602143806000},"page":"111805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1823-6102","authenticated-orcid":false,"given":"Dimitrios","family":"Vlachakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5189-5508","authenticated-orcid":false,"given":"Eleni","family":"Papakonstantinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7571-9883","authenticated-orcid":false,"given":"Thanasis","family":"Mitsis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Pierouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Io","family":"Diakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3098-5264","authenticated-orcid":false,"given":"George","family":"Chrousos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1001-0926","authenticated-orcid":false,"given":"Flora","family":"Bacopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.fct.2020.111805_bib1","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1128\/AAC.00957-12","article-title":"Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase","volume":"56","author":"Adedeji","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"21","key":"10.1016\/j.fct.2020.111805_bib2","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1128\/JVI.01131-10","article-title":"A conserved domain in the coronavirus membrane protein tail is important for virus assembly","volume":"84","author":"Arndt","year":"2010","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.fct.2020.111805_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response","volume":"14","author":"Astuti","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.fct.2020.111805_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.fct.2020.111805_bib5","article-title":"Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS-CoV-2 proteins","author":"Balasubramaniam","year":"2020","journal-title":"ChemRxiv"},{"key":"10.1016\/j.fct.2020.111805_bib6","doi-asserted-by":"crossref","first-page":"4389089","DOI":"10.1155\/2020\/4389089","article-title":"Sars-CoV-2 envelope and membrane proteins: structural differences linked to virus characteristics?","volume":"2020","author":"Bianchi","year":"2020","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.fct.2020.111805_bib7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.5114\/aoms.2020.94567","article-title":"State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2","volume":"16","author":"Borgio","year":"2020","journal-title":"Arch. Med. Sci."},{"issue":"6","key":"10.1016\/j.fct.2020.111805_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061770","article-title":"Silibinin and SARS-CoV-2: dual targeting of host cytokine storm and virus replication machinery for clinical management of COVID-19 patients","volume":"9","author":"Bosch-Barrera","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.fct.2020.111805_bib9","article-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study","author":"Cai","year":"2020","journal-title":"Engineering (Beijing)"},{"key":"10.1016\/j.fct.2020.111805_bib10","series-title":"Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls","author":"Cascella","year":"2020"},{"key":"10.1016\/j.fct.2020.111805_bib11","series-title":"Symptoms of Coronavirus (COVID-19). cdc.Gov\/coronavirus","year":"2020"},{"issue":"1","key":"10.1016\/j.fct.2020.111805_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11373-005-9035-9","article-title":"Modular organization of SARS coronavirus nucleocapsid protein","volume":"13","author":"Chang","year":"2006","journal-title":"J. Biomed. Sci."},{"issue":"5","key":"10.1016\/j.fct.2020.111805_bib13","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1128\/JVI.02001-08","article-title":"Multiple nucleic acid binding sites and intrinsic disorder of severe acute respiratory syndrome coronavirus nucleocapsid protein: implications for ribonucleocapsid protein packaging","volume":"83","author":"Chang","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.fct.2020.111805_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2013.12.009","article-title":"The SARS coronavirus nucleocapsid protein--forms and functions","volume":"103","author":"Chang","year":"2014","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.fct.2020.111805_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s13181-020-00777-5","article-title":"COVID-19: therapeutics and their toxicities","volume":"16","author":"Chary","year":"2020","journal-title":"J. Med. Toxicol. : official journal of the American College of Medical Toxicology"},{"issue":"11","key":"10.1016\/j.fct.2020.111805_bib16","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3201\/eid1011.040516","article-title":"Nucleocapsid protein as early diagnostic marker for SARS","volume":"10","author":"Che","year":"2004","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"10.1016\/j.fct.2020.111805_bib17","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jmb.2007.02.069","article-title":"Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA","volume":"368","author":"Chen","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.fct.2020.111805_bib18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.fct.2020.111805_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40475-020-00201-6","article-title":"The SARS-CoV-2 vaccine pipeline: an overview","volume":"7","author":"Chen","year":"2020","journal-title":"Current Tropical Medicine Reports"},{"issue":"12","key":"10.1016\/j.fct.2020.111805_bib20","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1128\/JVI.00060-11","article-title":"Identification of a Golgi complex-targeting signal in the cytoplasmic tail of the severe acute respiratory syndrome coronavirus envelope protein","volume":"85","author":"Cohen","year":"2011","journal-title":"J. Virol."},{"issue":"26","key":"10.1016\/j.fct.2020.111805_bib21","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.fct.2020.111805_bib22","doi-asserted-by":"crossref","first-page":"104742","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antivir. Res."},{"issue":"11","key":"10.1016\/j.fct.2020.111805_bib23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.it.2007.07.011","article-title":"Immunogenicity of protein therapeutics","volume":"28","author":"De Groot","year":"2007","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.fct.2020.111805_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/cpt.1844","article-title":"Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection","volume":"108","author":"Du","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.fct.2020.111805_bib25","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.peptides.2004.06.018","article-title":"Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide","volume":"25","author":"Du","year":"2004","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.fct.2020.111805_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2217\/fvl-2018-0144","article-title":"Membrane binding proteins of coronaviruses","volume":"14","author":"EA","year":"2019","journal-title":"Future Virol."},{"issue":"5","key":"10.1016\/j.fct.2020.111805_bib27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/acscentsci.0c00489","article-title":"Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19","volume":"6","author":"Eastman","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.fct.2020.111805_bib28","series-title":"Topological Analysis of SARS CoV-2 Main Protease","author":"Estrada","year":"2020"},{"issue":"6","key":"10.1016\/j.fct.2020.111805_bib29","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1086\/339041","article-title":"Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature","volume":"34","author":"Falc\u00f3","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fct.2020.111805_bib30","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/srep01686","article-title":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin","volume":"3","author":"Falzarano","year":"2013","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.fct.2020.111805_bib31","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/jmv.20953","article-title":"The membrane protein of SARS-CoV suppresses NF-kappaB activation","volume":"79","author":"Fang","year":"2007","journal-title":"J. Med. Virol."},{"issue":"10249","key":"10.1016\/j.fct.2020.111805_bib32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.fct.2020.111805_bib33","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.0c00168","article-title":"Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease","author":"Freitas","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"3","key":"10.1016\/j.fct.2020.111805_bib34","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.fct.2020.111805_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"6492","key":"10.1016\/j.fct.2020.111805_bib36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.fct.2020.111805_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","author":"Gordon","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.fct.2020.111805_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/v12020135","article-title":"Return of the coronavirus: 2019-nCoV","volume":"12","author":"Gralinski","year":"2020","journal-title":"Viruses"},{"issue":"24","key":"10.1016\/j.fct.2020.111805_bib39","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fct.2020.111805_bib40","first-page":"1","article-title":"In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel","author":"Gupta","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.fct.2020.111805_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2020.05.024","article-title":"Should we try SARS-CoV-2 helicase inhibitors for COVID-19 therapy?","author":"Habtemariam","year":"2020","journal-title":"Arch. Med. Res."},{"issue":"6","key":"10.1016\/j.fct.2020.111805_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006474","article-title":"Crystal structure of Middle East respiratory syndrome coronavirus helicase","volume":"13","author":"Hao","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.fct.2020.111805_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106055","article-title":"Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: insights from structures of protease and inhibitors","author":"He","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.fct.2020.111805_bib44","author":"Henderson"},{"key":"10.1016\/j.fct.2020.111805_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.fct.2020.111805_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2020-317393","article-title":"Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people","author":"Hippisley-Cox","year":"2020","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.fct.2020.111805_bib47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.fct.2020.111805_bib48","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1021\/bi036155b","article-title":"Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein","volume":"43","author":"Huang","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.fct.2020.111805_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.07.002","article-title":"Neutralization of SARS-CoV-2 by destruction of the prefusion spike","author":"Huo","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.fct.2020.111805_bib50","doi-asserted-by":"crossref","first-page":"103848","DOI":"10.1016\/j.compbiomed.2020.103848","article-title":"Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach","volume":"122","author":"Iftikhar","year":"2020","journal-title":"Comput. Biol. Med."},{"issue":"6","key":"10.1016\/j.fct.2020.111805_bib51","doi-asserted-by":"crossref","first-page":"101212","DOI":"10.1016\/j.isci.2020.101212","article-title":"Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1\/S2 site","volume":"23","author":"Jaimes","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.fct.2020.111805_bib52","series-title":"Classical Coronaviruses. Coronavirus Disease 2019 (COVID-19): Epidemiology, Pathogenesis, Diagnosis, and Therapeutics","first-page":"141","author":"Jaiswal","year":"2020"},{"issue":"12","key":"10.1016\/j.fct.2020.111805_bib53","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1093\/nar\/gkz409","article-title":"Delicate structural coordination of the severe acute respiratory syndrome coronavirus Nsp13 upon ATP hydrolysis","volume":"47","author":"Jia","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.fct.2020.111805_bib54","doi-asserted-by":"crossref","first-page":"104857","DOI":"10.1016\/j.antiviral.2020.104857","article-title":"A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19","volume":"180","author":"Jockusch","year":"2020","journal-title":"Antivir. Res."},{"issue":"44","key":"10.1016\/j.fct.2020.111805_bib55","doi-asserted-by":"crossref","first-page":"40847","DOI":"10.1074\/jbc.M106743200","article-title":"Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase","volume":"276","author":"Johnson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fct.2020.111805_bib56","doi-asserted-by":"crossref","DOI":"10.4155\/fmc-2020-0147","article-title":"Tackling SARS-CoV-2: proposed targets and repurposed drugs","author":"Joshi","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.fct.2020.111805_bib57","article-title":"Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease","volume":"1\u20138","author":"Kandeel","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.fct.2020.111805_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2020.04.009","article-title":"Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites","author":"Kang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.fct.2020.111805_bib59","article-title":"Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: an in silico investigation","volume":"1\u201312","author":"Kar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"5","key":"10.1016\/j.fct.2020.111805_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00187-20","article-title":"Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options","volume":"58","author":"Khan","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"11","key":"10.1016\/j.fct.2020.111805_bib61","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1016\/j.ejmech.2011.09.005","article-title":"2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV)","volume":"46","author":"Kim","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.fct.2020.111805_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-981-15-4814-7_3","article-title":"Morphology, genome organization, replication, and pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Kumar","year":"2020","journal-title":"Coronavirus Disease 2019 (COVID-19): Epidemiology, Pathogenesis, Diagnosis, and Therapeutics"},{"issue":"6","key":"10.1016\/j.fct.2020.111805_bib63","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.bmcl.2009.02.010","article-title":"Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase\/helicase","volume":"19","author":"Lee","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"16","key":"10.1016\/j.fct.2020.111805_bib64","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1016\/j.bmcl.2009.07.009","article-title":"Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase\/helicase by dihydroxychromone derivatives","volume":"19","author":"Lee","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.fct.2020.111805_bib65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.fct.2020.111805_bib66","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00483-20","article-title":"Updated approaches against SARS-CoV-2","volume":"64","author":"Li","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"16","key":"10.1016\/j.fct.2020.111805_bib67","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s00018-007-7103-1","article-title":"Coronavirus envelope protein: a small membrane protein with multiple functions","volume":"64","author":"Liu","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.fct.2020.111805_bib68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2478\/jtim-2020-0003","article-title":"Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management","volume":"8","author":"Liu","year":"2020","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.fct.2020.111805_bib69","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cca.2020.05.044","article-title":"COVID-19: transmission, prevention, and potential therapeutic opportunities","volume":"508","author":"Lotfi","year":"2020","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"issue":"1","key":"10.1016\/j.fct.2020.111805_bib70","first-page":"1","article-title":"Optimisation of a potent series of HCV helicase drug candidates","volume":"4","author":"Loukatou","year":"2015","journal-title":"J. Mol. Biochem."},{"issue":"1","key":"10.1016\/j.fct.2020.111805_bib71","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11262-010-0544-x","article-title":"SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism","volume":"42","author":"Lu","year":"2011","journal-title":"Virus Gene."},{"issue":"12","key":"10.1016\/j.fct.2020.111805_bib72","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.febslet.2005.03.080","article-title":"The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1","volume":"579","author":"Luo","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.fct.2020.111805_bib73","doi-asserted-by":"crossref","first-page":"198070","DOI":"10.1016\/j.virusres.2020.198070","article-title":"COVID-19: review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking","volume":"286","author":"Magro","year":"2020","journal-title":"Virus Res."},{"issue":"8","key":"10.1016\/j.fct.2020.111805_bib74","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/v6082991","article-title":"The coronavirus nucleocapsid is a multifunctional protein","volume":"6","author":"McBride","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.fct.2020.111805_bib75","author":"McCallum"},{"key":"10.1016\/j.fct.2020.111805_bib76","doi-asserted-by":"crossref","first-page":"104859","DOI":"10.1016\/j.phrs.2020.104859","article-title":"Candidate drugs against SARS-CoV-2 and COVID-19","volume":"157","author":"McKee","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"19","key":"10.1016\/j.fct.2020.111805_bib77","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.19.2000620","article-title":"Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020","volume":"25","author":"Michelozzi","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.fct.2020.111805_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2020.04.008","article-title":"Structural elucidation of SARS-CoV-2 vital proteins: computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase","author":"Mirza","year":"2020","journal-title":"J Pharm Anal"},{"issue":"8","key":"10.1016\/j.fct.2020.111805_bib79","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0149-2918(00)80064-8","article-title":"Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity","volume":"22","author":"Moyle","year":"2000","journal-title":"Clin. Therapeut."},{"issue":"5","key":"10.1016\/j.fct.2020.111805_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9050320","article-title":"Feasibility of known RNA polymerase inhibitors as anti-SARS-CoV-2 drugs","volume":"9","author":"Neogi","year":"2020","journal-title":"Pathogens"},{"issue":"16","key":"10.1016\/j.fct.2020.111805_bib81","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1128\/JVI.00645-06","article-title":"Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy","volume":"80","author":"Neuman","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.fct.2020.111805_bib82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","article-title":"A structural analysis of M protein in coronavirus assembly and morphology","volume":"174","author":"Neuman","year":"2011","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.fct.2020.111805_bib83","first-page":"137","article-title":"Structure-function relationships among RNA-dependent RNA polymerases","volume":"320","author":"Ng","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.fct.2020.111805_bib84","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.fct.2020.111805_bib85","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1039\/C5MB00706B","article-title":"An updated evolutionary study of Flaviviridae NS3 helicase and NS5 RNA-dependent RNA polymerase reveals novel invariable motifs as potential pharmacological targets","volume":"12","author":"Papageorgiou","year":"2016","journal-title":"Mol. Biosyst."},{"issue":"8","key":"10.1016\/j.fct.2020.111805_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/v11080745","article-title":"A comprehensive superposition of viral polymerase structures","volume":"11","author":"Peersen","year":"2019","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.fct.2020.111805_bib87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3892\/mmr.2020.11127","article-title":"Obesity - a risk factor for increased COVID-19 prevalence, severity and lethality (Review)","volume":"22","author":"Petrakis","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.fct.2020.111805_bib88","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1099\/jmm.0.001203","article-title":"Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2","volume":"69","author":"Pokhrel","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.fct.2020.111805_bib89","doi-asserted-by":"crossref","DOI":"10.15698\/cst2020.04.216","article-title":"Coronavirus infections: epidemiological, clinical and immunological features and hypotheses","author":"Raoult","year":"2020","journal-title":"Cell Stress"},{"key":"10.1016\/j.fct.2020.111805_bib90","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2016.12.011","article-title":"Sofosbuvir: an antiviral drug with potential efficacy against Zika infection","volume":"55","author":"Reznik","year":"2017","journal-title":"Int. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.fct.2020.111805_bib91","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/mol.114.094862","article-title":"Characterization of ritonavir-mediated inactivation of cytochrome P450 3A4","volume":"86","author":"Rock","year":"2014","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.fct.2020.111805_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051267","article-title":"A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping","volume":"9","author":"Romano","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.fct.2020.111805_bib93","article-title":"SARS-CoV-2 and SARS-CoV: virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12)","author":"Ruan","year":"2020","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.fct.2020.111805_bib94","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/JVI.01570-10","article-title":"The hydrophobic domain of infectious bronchitis virus E protein alters the host secretory pathway and is important for release of infectious virus","volume":"85","author":"Ruch","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.fct.2020.111805_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2020.05.012","article-title":"Structural proteins in severe acute respiratory syndrome coronavirus-2","author":"Satarker","year":"2020","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.fct.2020.111805_bib96","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12038-020-00067-w","article-title":"Drug targets for COVID-19 therapeutics: ongoing global efforts","volume":"45","author":"Saxena","year":"2020","journal-title":"J. Biosci."},{"issue":"Suppl. l_6","key":"10.1016\/j.fct.2020.111805_bib97","doi-asserted-by":"crossref","first-page":"vi3","DOI":"10.1093\/ndt\/gfh1092","article-title":"Factors influencing the immunogenicity of therapeutic proteins","volume":"20","author":"Schellekens","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.fct.2020.111805_bib98","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.fct.2020.111805_bib99","series-title":"ACE2 Polypeptide","author":"Schuster","year":"2010"},{"issue":"21","key":"10.1016\/j.fct.2020.111805_bib100","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"396","key":"10.1016\/j.fct.2020.111805_bib101","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.fct.2020.111805_bib102","first-page":"505","article-title":"Small envelope protein E of SARS: cloning, expression, purification, CD determination, and bioinformatics analysis","volume":"24","author":"Shen","year":"2003","journal-title":"Acta Pharmacol. Sin."},{"issue":"28","key":"10.1016\/j.fct.2020.111805_bib103","doi-asserted-by":"crossref","first-page":"E4005","DOI":"10.1073\/pnas.1602591113","article-title":"Structural basis of viral RNA-dependent RNA polymerase catalysis and translocation","volume":"113","author":"Shu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.fct.2020.111805_bib104","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12250-020-00242-1","article-title":"SARS-Coronavirus-2 Nsp13 possesses NTPase and RNA helicase activities that can Be inhibited by bismuth salts","volume":"35","author":"Shu","year":"2020","journal-title":"Virol. Sin."},{"issue":"16","key":"10.1016\/j.fct.2020.111805_bib105","doi-asserted-by":"crossref","first-page":"10669","DOI":"10.1074\/jbc.M509233200","article-title":"The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells","volume":"281","author":"Surjit","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.fct.2020.111805_bib106","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.chembiol.2005.01.006","article-title":"The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus","volume":"12","author":"Tanner","year":"2005","journal-title":"Chem. Biol."},{"issue":"22","key":"10.1016\/j.fct.2020.111805_bib107","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1091\/mbc.e10-04-0338","article-title":"The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis","volume":"21","author":"Teoh","year":"2010","journal-title":"Mol. Biol. Cell"},{"issue":"11","key":"10.1016\/j.fct.2020.111805_bib108","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2174\/138161206776361156","article-title":"Antiviral therapy targeting viral polymerase","volume":"12","author":"Tsai","year":"2006","journal-title":"Curr. Pharmaceut. Des."},{"issue":"17","key":"10.1016\/j.fct.2020.111805_bib109","doi-asserted-by":"crossref","first-page":"12862","DOI":"10.1074\/jbc.M109.030270","article-title":"Self-assembly of severe acute respiratory syndrome coronavirus membrane protein","volume":"285","author":"Tseng","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.fct.2020.111805_bib110","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/BJ20131461","article-title":"The SARS-coronavirus membrane protein induces apoptosis via interfering with PDK1-PKB\/Akt signalling","volume":"464","author":"Tsoi","year":"2014","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.fct.2020.111805_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072657","article-title":"A review of SARS-CoV-2 and the ongoing clinical trials","volume":"21","author":"Tu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.fct.2020.111805_bib112","doi-asserted-by":"crossref","first-page":"127377","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV-2 main protease as drug target","volume":"30","author":"Ullrich","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.fct.2020.111805_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/v10020076","article-title":"RNA dependent RNA polymerases: insights from structure, function and evolution","volume":"10","author":"Venkataraman","year":"2018","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.fct.2020.111805_bib114","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.bbamem.2013.05.008","article-title":"Analysis of SARS-CoV E protein ion channel activity by tuning the protein and lipid charge","volume":"1828","author":"Verdia-Baguena","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.fct.2020.111805_bib115","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1038\/s41467-020-17496-8","article-title":"Structural basis of RNA cap modification by SARS-CoV-2","volume":"11","author":"Viswanathan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.fct.2020.111805_bib116","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.7717\/peerj.85","article-title":"Molecular modeling and pharmacophore elucidation study of the Classical Swine Fever virus helicase as a promising pharmacological target","volume":"1","author":"Vlachakis","year":"2013","journal-title":"PeerJ"},{"key":"10.1016\/j.fct.2020.111805_bib117","first-page":"645348","article-title":"3D molecular modelling study of the H7N9 RNA-dependent RNA polymerase as an emerging pharmacological target","author":"Vlachakis","year":"2013","journal-title":"Influenza Res Treat"},{"key":"10.1016\/j.fct.2020.111805_bib118","first-page":"108910","article-title":"Space constrained homology modelling: the paradigm of the RNA-dependent RNA polymerase of dengue (type II) virus","author":"Vlachakis","year":"2013","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.fct.2020.111805_bib119","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.7717\/peerj.74","article-title":"A holistic evolutionary and structural study of flaviviridae provides insights into the function and inhibition of HCV helicase","volume":"1","author":"Vlachakis","year":"2013","journal-title":"PeerJ"},{"key":"10.1016\/j.fct.2020.111805_bib120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11786-016-0287-8","article-title":"Advanced protein alignments based on sequence, structure and hydropathy profiles; the paradigm of the viral polymerase enzyme","volume":"11","author":"Vlachakis","year":"2017","journal-title":"Mathematics in Computer Science"},{"key":"10.1016\/j.fct.2020.111805_bib121","author":"Walker"},{"issue":"2","key":"10.1016\/j.fct.2020.111805_bib122","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.fct.2020.111805_bib123","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1743-422X-7-99","article-title":"Interactions of SARS coronavirus nucleocapsid protein with the host cell proteasome subunit p42","volume":"7","author":"Wang","year":"2010","journal-title":"Virol. J."},{"issue":"3","key":"10.1016\/j.fct.2020.111805_bib124","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"issue":"7594","key":"10.1016\/j.fct.2020.111805_bib125","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.fct.2020.111805_bib126","series-title":"COVID-19 and the Use of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers","author":"WHO","year":"2020"},{"key":"10.1016\/j.fct.2020.111805_bib127","series-title":"Weekly Epidemiological Update","author":"WHO","year":"2020"},{"issue":"5","key":"10.1016\/j.fct.2020.111805_bib128","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.fct.2020.111805_bib129","first-page":"1","article-title":"An update on current therapeutic drugs treating COVID-19","author":"Wu","year":"2020","journal-title":"Current pharmacology reports"},{"issue":"4","key":"10.1016\/j.fct.2020.111805_bib130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.fct.2020.111805_bib131","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.dsx.2020.07.030","article-title":"SARS-CoV-2-host dynamics: increased risk of adverse outcomes of COVID-19 in obesity","volume":"14","author":"Yadav","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"8","key":"10.1016\/j.fct.2020.111805_bib132","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.biocel.2006.02.003","article-title":"Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT\/enhancer binding protein","volume":"38","author":"Yan","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"42","key":"10.1016\/j.fct.2020.111805_bib133","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1039\/b709515e","article-title":"Inhibition of SARS coronavirus helicase by bismuth complexes","author":"Yang","year":"2007","journal-title":"Chem Commun (Camb)"},{"issue":"34","key":"10.1016\/j.fct.2020.111805_bib134","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1002\/anie.200701021","article-title":"Bismuth complexes inhibit the SARS coronavirus","volume":"46","author":"Yang","year":"2007","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"4","key":"10.1016\/j.fct.2020.111805_bib135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jphs.2018.06.012","article-title":"Q63, a novel DENV2 RdRp non-nucleoside inhibitor, inhibited DENV2 replication and infection","volume":"138","author":"Yao","year":"2018","journal-title":"J. Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.fct.2020.111805_bib136","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1128\/JVI.01472-06","article-title":"Role of the coronavirus E viroporin protein transmembrane domain in virus assembly","volume":"81","author":"Ye","year":"2007","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.fct.2020.111805_bib137","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.7150\/ijbs.45472","article-title":"Zoonotic origins of human coronaviruses","volume":"16","author":"Ye","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"6498","key":"10.1016\/j.fct.2020.111805_bib138","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.fct.2020.111805_bib139","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Canc."},{"issue":"12","key":"10.1016\/j.fct.2020.111805_bib140","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.bmcl.2012.04.081","article-title":"Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13","volume":"22","author":"Yu","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.fct.2020.111805_bib141","doi-asserted-by":"crossref","first-page":"108427","DOI":"10.1016\/j.clim.2020.108427","article-title":"COVID-19 pathophysiology: a review","volume":"215","author":"Yuki","year":"2020","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.fct.2020.111805_bib142","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2008.01.096","article-title":"The nucleocapsid protein of SARS-associated coronavirus inhibits B23 phosphorylation","volume":"369","author":"Zeng","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.fct.2020.111805_bib143","doi-asserted-by":"crossref","first-page":"eabb3405","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.fct.2020.111805_bib144","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1021\/acs.jpclett.0c00571","article-title":"Novel coronavirus polymerase and nucleotidyl-transferase structures: potential to target new outbreaks","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Phys. Chem. Lett."},{"issue":"10","key":"10.1016\/j.fct.2020.111805_bib145","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.7150\/ijbs.45053","article-title":"SARS-CoV-2: an emerging coronavirus that causes a global threat","volume":"16","author":"Zheng","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"14","key":"10.1016\/j.fct.2020.111805_bib146","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1128\/JVI.00133-08","article-title":"The nucleocapsid protein of severe acute respiratory syndrome coronavirus inhibits cell cytokinesis and proliferation by interacting with translation elongation factor 1alpha","volume":"82","author":"Zhou","year":"2008","journal-title":"J. Virol."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691520306955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691520306955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:05:34Z","timestamp":1759529134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691520306955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":146,"alternative-id":["S0278691520306955"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2020.111805","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2020.111805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111805"}}